Merit Research Development from 2010 to 2026
| MM3 Stock | EUR 69.00 1.00 1.47% |
Research Development | First Reported 2016-12-31 | Previous Quarter 24.4 M | Current Value 24 M | Quarterly Volatility 3.7 M |
Check Merit Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Merit Medical's main balance sheet or income statement drivers, such as Interest Expense of 37.7 M, Selling General Administrative of 307 M or Total Revenue of 1 B, as well as many indicators such as . Merit financial statements analysis is a perfect complement when working with Merit Medical Valuation or Volatility modules.
Merit | Research Development |
The Research Development trend for Merit Medical Systems offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Merit Medical is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Merit Medical's Research Development Growth Pattern
Below is the plot of the Research Development of Merit Medical Systems over the last few years. It is Merit Medical's Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Merit Medical's overall financial position and show how it may be relating to other accounts over time.
| Research Development | 10 Years Trend |
|
Research Development |
| Timeline |
Merit Research Development Regression Statistics
| Arithmetic Mean | 58,560,700 | |
| Geometric Mean | 55,181,537 | |
| Coefficient Of Variation | 35.70 | |
| Mean Deviation | 17,518,506 | |
| Median | 57,537,000 | |
| Standard Deviation | 20,908,312 | |
| Sample Variance | 437.2T | |
| Range | 64M | |
| R-Value | 0.92 | |
| Mean Square Error | 75.4T | |
| R-Squared | 0.84 | |
| Slope | 3,791,040 | |
| Total Sum of Squares | 6994.5T |
Merit Research Development History
About Merit Medical Financial Statements
Merit Medical stakeholders use historical fundamental indicators, such as Merit Medical's Research Development, to determine how well the company is positioned to perform in the future. Although Merit Medical investors may analyze each financial statement separately, they are all interrelated. For example, changes in Merit Medical's assets and liabilities are reflected in the revenues and expenses on Merit Medical's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Merit Medical Systems. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Research Development | 100.6 M | 68 M |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out the analysis of Merit Medical Correlation against competitors. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.